# Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

> **NCT05530759** · — · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 50 (estimated)

## Conditions studied

- Hematopoietic and Lymphoid System Neoplasm
- Metastatic Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biopsy Specimen
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Medical Chart Review

## Key facts

- **NCT ID:** NCT05530759
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-29
- **Primary completion:** 2027-04-07
- **Final completion:** 2028-04-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05530759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05530759, "Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05530759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*